- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07736326
The Effect of Pecha-Kucha Method Training on the Knowledge and Skills of Nurses Regarding Anticoagulant Drug Administration
July 25, 2026 updated by: Demet İnangil, PhD, Istanbul Saglik Bilimleri University
The research was conducted between January 2025 and May 2025 using a randomized controlled experimental design with a pre-test-post-test pproach.
A total of 76 nurses working at a state university hospital in Istanbul participated in the study.
The experimental group received training through the Pecha-Kucha method, while the control group received traditional instruction.
Data were collected using the Individual Characteristics Form, the Nurses' Knowledge Assessment Form for Anticoagulant Drug Administration, the Skill Assessment Form for Anticoagulant Drug Administration, and the Visual Analog Scale.
Study Overview
Study Type
Interventional
Enrollment (Actual)
76
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Istanbul
-
Üsküdar, Istanbul, Turkey (Türkiye), 34
- University of Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- volunteered to participate
- administered anticoagulant medication in their clinic.
Exclusion Criteria:
- Non-volunteered to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Conventional
The training was conducted with 38 nurses who met the traditional presentation training research criteria.
The training was completed in separate sessions of 8-10 nurses.
Groups were planned considering the nurses' working days and hours.
The researcher provided 25-30 minutes of "Anticoagulant Drug Administration" training using a PowerPoint presentation prepared in accordance with current literature and delivered face-to-face.
|
|
|
Experimental: Pecha-Kucha
The presentation, conducted by the researcher using the Pecha-Kucha method in accordance with current literature, consisted of 20 slides with minimal text and a high concentration of visuals related to anticoagulant drugs, each slide presented for 20 seconds, totaling 6 minutes and 40 seconds.
The instructor was positioned to be more active and the center of attention.
|
The presentation, conducted by the researcher using the Pecha-Kucha method in accordance with current literature, consisted of 20 slides with minimal text and a high concentration of visuals related to anticoagulant drugs, each slide presented for 20 seconds, totaling 6 minutes and 40 seconds.
The instructor was positioned to be more active and the center of attention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
"Anticoagulant Drug Administration Knowledge Level Assessment Form"
Time Frame: After training Day 1
|
After training Day 1
|
|
Anticoagulant Drug Administration Skills Assessment Form
Time Frame: after training Day 1
|
after training Day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Visual Analog Scale for Satisfaction
Time Frame: after training Day 1
|
after training Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 2, 2025
Primary Completion (Actual)
May 31, 2025
Study Completion (Actual)
May 31, 2025
Study Registration Dates
First Submitted
July 2, 2026
First Submitted That Met QC Criteria
July 25, 2026
First Posted (Actual)
July 30, 2026
Study Record Updates
Last Update Posted (Actual)
July 30, 2026
Last Update Submitted That Met QC Criteria
July 25, 2026
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2023/20/1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
all IPD that underlie results in a publication
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.